Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qinggan Yishen Qufeng is a traditional Chinese medicine (TCM) compound formula used primarily for the prevention and treatment of hypertension, especially in high-risk populations. The formula is composed of multiple herbal ingredients and is designed to target several pathophysiological mechanisms associated with hypertension. Its proposed mechanisms include improving intestinal permeability, modulating gut microbiota composition, reducing systemic inflammation, and protecting renal function. Studies suggest that it may regulate metabolic pathways mediated by endothelial nitric oxide synthase (eNOS), improve microecology dysbiosis in the gut, and enhance vascular endothelial function[1][6][7]. The formula has been investigated in clinical trials for its efficacy in managing high-risk hypertension[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qinggan Yishen Qufeng.